Viral exploitation of host SOCS protein functions

Journal of Virology

Volumn 85, Issue 5, 2011, Pages 1912-1921

  Akhtar, Lisa Nowoslawski ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; JANUS KINASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING;

EBOLA VIRUS; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA VIRUS; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS; VIRUS SURVIVAL;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; VIRUS DISEASES; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUSES;

EID: 79551703144     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01857-10     Document Type: Short Survey

References (79)

1. Ahmed, C. M., et al. 2010. Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling. J. Immunol. 185:1103-1113.
2. Akhtar, L. N., et al. 2010. Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages. J. Immunol. 185:2393-2404.
3. Bansal, G. P., A. Malaspina, and J. Flores. 2010. Future paths for HIV vaccine research: exploiting results from recent clinical trials and current scientific advances. Curr. Opin. Mol. Ther. 12:39-46.
4. Biggs, B. A., M. Hewish, S. Kent, K. Hayes, and S. M. Crowe. 1995. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J. Immunol. 154:6132-6139.
5. Bode, J. G., E. D. Brenndorfer, and D. Haussinger. 2007. Subversion of innate host antiviral strategies by the hepatitis C virus. Arch. Biochem. Biophys. 462:254-265.
6. Bode, J. G., et al. 2003. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J. 17:488-490.
7. Cecilia, D., C. Kleeberger, A. Munoz, J. V. Giorgi, and S. Zolla-Pazner. 1999. A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects. J. Infect. Dis. 179:1365-1374.
8. Charles, E. D., and L. B. Dustin. 2009. Hepatitis C virus-induced cryoglobulinemia. Kidney Int. 76:818-824.
9. Chen, X. P., et al. 2002. Pim serine/threonine kinases regulate the stability of Socs-1 protein. Proc. Natl. Acad. Sci. U. S. A. 99:2175-2180.
10. Cheng, S. M., et al. 2009. HIV-1 transactivator protein induction of suppressor of cytokine signaling-2 contributes to dysregulation of IFNγ signaling. Blood 113:5192-5201.
11. Chiu, Y. L., and W. C. Greene. 2008. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26:317-353.
12. Chiu, Y. L., et al. 2005. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435:108-114.
13. Decman, V., P. R. Kinchington, S. A. Harvey, and R. L. Hendricks. 2005. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. 79:10339-10347.
14. Dimitriou, I. D., et al. 2008. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol. Rev. 224:265-283.
15. Ehlting, C., et al. 2007. Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF-alpha involves activation of the MKK6/p38MAPK/MK2 cascade. J. Immunol. 178:2813-2826. (Pubitemid 46333159)
16. Fenner, J. E., et al. 2006. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat. Immunol. 7:33-39.
17. Forde, K. A., and K. R. Reddy. 2009. Hepatitis C virus infection and immunomodulatory therapies. Clin. Liver Dis. 13:391-401.
18. Frey, K. G., et al. 2009. HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion. J. Immunol. 183:1253-1262.
19. Fried, M. W., et al. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347:975-982.
20. Frobøse, H., et al. 2006. Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol. Endocrinol. 20:1587-1596.
21. Haan, S., et al. 2003. Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation. J. Biol. Chem. 278:31972-31979.
22. Hanada, T., et al. 2005. Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J. Immunol. 174:4325-4332. (Pubitemid 40396015)
23. Hanada, T., et al. 2001. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box. J. Biol. Chem. 276:40746-40754.
24. Hashimoto, K., et al. 2009. RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules. Virology 391:162-170.
25. He, Y., W. Zhang, R. Zhang, H. Zhang, and W. Min. 2006. SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation. J. Biol. Chem. 281:5559-5566.
26. Imanaka, K., et al. 2005. Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy. J. Viral Hepat. 12:130-138. (Pubitemid 40342170)
27. Kawaguchi, T., et al. 2004. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am. J. Pathol. 165:1499-1508.
28. Kim, K., K. H. Kim, and J. Cheong. 2010. Hepatitis B virus X protein impairs hepatic insulin signaling through degradation of IRS1 and induction of SOCS3. PLoS One 5:e8649.
29. Kim, K. A., et al. 2009. Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection. J. Hepatol. 50:705-711.
30. Koeberlein, B., et al. 2010. Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Res. 148:51-59.
31. Kreisberg, J. F., W. Yonemoto, and W. C. Greene. 2006. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J. Exp. Med. 203:865-870.
32. Kubo, M., T. Hanada, and A. Yoshimura. 2003. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4:1169-1176.
33. Levrero, M. 2006. Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene 25:3834-3847. (Pubitemid 43980479)
34. Mahller, Y. Y., et al. 2008. Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication. Cancer Gene Ther. 15:733-741.
35. Malim, M. H., and M. Emerman. 2008. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3:388-398. (Pubitemid 351784365)
36. Mansell, A., et al. 2006. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7:148-155.
37. Mehta, S. H., et al. 2003. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38:50-56. (Pubitemid 36775795)
38. Mehta, S. H., et al. 2000. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann. Intern. Med. 133:592-599.
39. Moorman, J., et al. 2009. Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection. Immunology 128:227-235.
40. Moutsopoulos, N. M., et al. 2006. Regulation of the tonsil cytokine milieu favors HIV susceptibility. J. Leukoc. Biol. 80:1145-1155.
41. Naghavi, M. H., and S. P. Goff. 2007. Retroviral proteins that interact with the host cell cytoskeleton. Curr. Opin. Immunol. 19:402-407.
42. Nakagawa, R., et al. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17:677-687. (Pubitemid 35351512)
43. Nishi, M., et al. 2009. Requirement for microtubule integrity in the SOCS1-mediated intracellular dynamics of HIV-1 Gag. FEBS Lett. 583:1243-1250.
44. Ogata, H., et al. 2006. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 131:179-193. (Pubitemid 44015756)
45. Okumura, A., P. M. Pitha, A. Yoshimura, and R. N. Harty. 2010. Interaction between Ebola virus glycoprotein and host Toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1. J. Virol. 84:27-33.
46. Paladino, P., and K. L. Mossman. 2009. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J. Interferon Cytokine Res. 29:599-607.
47. Pauli, E. K., et al. 2008. Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog. 4:e1000196.
48. Peltola, K. J., et al. 2004. Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3. Blood 103:3744-3750. (Pubitemid 38596290)
49. Persico, M., et al. 2007. Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy. Hepatology 46:1009-1015. (Pubitemid 350144765)
50. Persico, M., et al. 2008. Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. Gut 57:507-515. (Pubitemid 351442535)
51. Piessevaux, J., D. Lavens, F. Peelman, and J. Tavernier. 2008. The many faces of the SOCS box. Cytokine Growth Factor Rev. 19:371-381.
52. Pothlichet, J., M. Chignard, and M. Si-Tahar. 2008. Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J. Immunol. 180:2034-2038.
53. Qiao, X., et al. 2006. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol. 7:302-310.
54. Rui, L., M. Yuan, D. Frantz, S. Shoelson, and M. F. White. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277:42394-42398.
55. Ryo, A., et al. 2003. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12:1413-1426. (Pubitemid 38037011)
56. Ryo, A., et al. 2008. SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag. Proc. Natl. Acad. Sci. U. S. A. 105:294-299.
57. Sakurai, H., et al. 2008. Adenoviral expression of suppressor of cytokine signaling-1 reduces adenovirus vector-induced innate immune responses. J. Immunol. 180:4931-4938.
58. Sasaki, A., et al. 2003. The N-terminal truncated isoform of SOCS3 translated from an alternative initiation AUG codon under stress conditions is stable due to the lack of a major ubiquitination site, Lys-6. J. Biol. Chem. 278:2432-2436.
59. Sato, M., et al. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548.
60. Shao, R. X., et al. 2010. Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner. J. Virol. 84:6060-6069.
61. Shen, L., K. Evel-Kabler, R. Strube, and S. Y. Chen. 2004. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat. Biotechnol. 22:1546-1553.
62. Sheng, Z., D. Pennica, W. I. Wood, and K. R. Chien. 1996. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 122:419-428.
63. Song, M. M., and K. Shuai. 1998. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273:35056-35062.
64. Song, X. T., et al. 2006. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells. PLoS Med. 3:e11.
65. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
66. Stavnezer, J., J. E. Guikema, and C. E. Schrader. 2008. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26:261-292.
67. Strauss, J. H., and E. G. Strauss. 2002. Host defense against viral infection and viral counter defenses, p. 303-346. In J. H. Strauss and E. G. Strauss (ed.), Viruses and human disease. Academic Press, San Diego, CA.
68. Stremlau, M., et al. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427:848-853. (Pubitemid 38297747)
69. Vázquez, N., T. Greenwell-Wild, S. Rekka, J. M. Orenstein, and S. M. Wahl. 2006. Mycobacterium avium-induced SOCS contributes to resistance to IFNgamma-mediated mycobactericidal activity in human macrophages. J. Leukoc. Biol. 80:1136-1144.
70. Viswanatha, D. S., and A. Dogan. 2007. Hepatitis C virus and lymphoma. J. Clin. Pathol. 60:1378-1383.
71. Waiboci, L. W., et al. 2007. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist. J. Immunol. 178:5058-5068. (Pubitemid 46595289)
72. Xu, Y., et al. 2009. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol. Immunol. 46:2640-2646.
73. Yajima, T., et al. 2006. Innate defense mechanism against virus infection within the cardiac myocyte requiring gp130-STAT3 signaling. Circulation 114:2364-2373. (Pubitemid 44847453)
74. Yao, Z. Q., D. Prayther, C. Trabue, Z. P. Dong, and J. Moorman. 2008. Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein. Immunology 125:197-207.
75. Yasukawa, H., et al. 2003. The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. J. Clin. Invest. 111:469-478.
76. Yokota, S., N. Yokosawa, T. Okabayashi, T. Suzutani, and N. Fujii. 2005. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 confers efficient viral replication. Virology 338:173-181. (Pubitemid 40835935)
77. Yokota, S., et al. 2004. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J. Virol. 78:6282-6286. (Pubitemid 38715926)
78. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7:454-465.
79. Zhao, D. C., T. Yan, L. Li, S. You, and C. Zhang. 2007. Respiratory syncytial virus inhibits interferon-alpha-inducible signaling in macrophage-like U937 cells. J. Infect. 54:393-398. (Pubitemid 46395017)